White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide – Chapter 9: Speaker Programs for HCPs
approved slides. It is inappropriate for a speaker to skip required safety slides or to present no slides
during a program.
In very limited circumstances, the Review Committee may permit a speaker to present slides that are
not contained in the approved speaker kit. Colleagues must submit the speaker’s proposed slides for
RC review and approval prior to the speaker program (the “Exceptions Process”). Please refer to
EZSpeak for details on the Exceptions Process.
Remember, any information provided by a speaker, whether verbally or as part of a slide presentation,
must be:
Accurate and truthful;
Consistent with product labeling;
Supported by substantiated and scientifically-sound data; and
Appropriately balanced with information on both benefits and risks.
Investigational or unapproved uses of Pfizer products may not be proactively discussed. Off-label
information may be provided only in response to a specific unsolicited question from an attendee.
Before briefly answering the question, the speaker must state that the information to be discussed is
off-label and is based on the speaker’s personal experience or opinion. The speaker may not use
unapproved slides to support the answer. If the HCP asking the question requires additional
information or the question cannot be adequately answered briefly, the speaker (or Pfizer
representative) must refer the HCP to the Medical Information department.
Speakers may not engage in a consultation during the speaker program and may not review charts or
files of individual patients in an attendee’s practice.
158
Rev. 09/12
Page 7 of 25